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Abstract
: Many households in low-and-middle income countries faceBackground
the additional burden of crippling out-of-pocket expenditure when faced
with a diagnosis of life-limiting illness. Available evidence suggests that
receipt of palliative care supports cost-savings for cancer-affected
households. This study will explore the relationship between receipt of
palliative care, total household out-of-pocket expenditure on health and
wellbeing following a first-time diagnosis of advanced cancer at Queen
Elizabeth Central Hospital in Blantyre, Malawi.
: Patients and their primary family caregivers will be recruited atProtocol
the time of cancer diagnosis.  Data on healthcare utilisation, related costs,
coping strategies and wellbeing will be gathered using new and existing
questionnaires (the Patient-and-Carer Cancer Cost Survey, EQ-5D-3L and
the Integrated Palliative Care Outcome Score). Surveys will be repeated at
one, three and six months after diagnosis. In the event of the patient’s
death, a brief five-item questionnaire on funeral costs will be administered
to caregivers not less than two weeks following the date of death.
Descriptive and Poisson regression analyses will assess the relationship
between exposure to palliative care and total household expenditure from
baseline to six months. A sample size of 138 households has been
calculated in order to detect a medium effect (as determined by Cohen’s f
=0.15) of receipt of palliative care in a regression model for change in total
household out-of-pocket expenditure as a proportion of annual household
income.
: The study has received ethical approval.Ethics and dissemination
Results will be reported using STROBE guidelines and disseminated
through scientific meetings, open access publications and a national
stakeholder meeting. 
: This study will provide data on expenditure for healthcare byConclusions
households affected by cancer in Malawi. We also explore whether receipt
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 households affected by cancer in Malawi. We also explore whether receipt
of palliative care is associated with a reduction in out-of-pocket expenditure
at household level.
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Introduction
The impact of a diagnosis of cancer on households in low and 
middle-income countries (LMICs) is dramatic. A study of over 
9000 cancer patients in South East Asia reported that 75% of 
patients had either died or faced financial catastrophe twelve 
months from diagnosis1. In African settings, cancer is asso-
ciated with high mortality, as well as catastrophic financial, 
psychological and spiritual morbidity2,3. Many households 
experience cancer diagnoses when they would expect to be at 
their most economically productive4. For the few patients who 
are able to access potentially curative cancer therapy, default 
rates are high5,6.
The Lancet Commission on Palliative Care and Pain Relief states 
that ‘access to palliative care and pain relief is a health equity 
and human rights imperative which has been largely ignored 
in the goal to achieve Universal Health Coverage (UHC)’7. Pal-
liative care is an approach which improves quality of life of 
patients and families affected by life limiting illnesses8. Provi-
sion of palliative care should not be limited to those thought 
to be in ‘terminal’ or ‘end of life’ situations; these terms lack 
clear definition and risk a ‘missed opportunity to do better for 
patients’9. Cost savings have been associated with a variety 
of models of delivery of palliative care, though the majority 
of data are reported from high income settings, and from 
a health systems rather than patient perspective10,11.
Out-of-pocket expenditure (OOPE) accounts for 23% of glo-
bal health expenditure and 45% of health expenditure in the 
developing world12. In Malawi – where the Essential Health 
Package (EHP) is provided at no cost to users at the point of 
care – OOPE remains a significant burden on rural households, 
accounting for an estimated 13–22% of health expenditure13. 
Interventions aimed at reducing the burden of non-communicable 
diseases can play a key role in global development, facilitating 
progress towards the Sustainable Development Goals including 
– and beyond – health14–16.
In this study we will explore the association between receipt 
of palliative care and total household expenditure on health 
(as a proportion of total household income), and wellbeing for 
those affected by a first-time clinical diagnosis of Kaposi’s 
sarcoma, cervical or oesophageal cancer or hepatocellular 
carcinoma at Queen Elizabeth Central Hospital in Blantyre, 
Malawi. We hypothesised that, as a result of pain and symptom 
management and provision of information about their condi-
tion, patients receiving palliative care will maintain or improve 
their wellbeing whilst requiring fewer repeat visits to health 
providers. In this way, receipt of palliative care will be associ-
ated with a reduction in total household expenditure on health 
over time, whilst patient (and carer) wellbeing is maintained 
or improved.
Protocol
Details of ethical issues and ethical approval received
This study has undergone ethical review by, and received 
approval from, the College of Medicine Research Ethics 
Committee in Blantyre, Malawi (P.05/18/2395) and the Liverpool 
School of Tropical Medicine Research Ethics Committee 
(18/046). All participants (patients and household carers) will be 
invited to give written informed consent to take part in the study. 
All electronic and paper-based data will be anonymised.
Setting
Malawi is a low-income country in Central Southern Africa. 
Health services are provided free at the point of care through a 
network of community and hospital-based services supported 
by government and faith-based funding across 28 districts17. 
There are four publicly funded tertiary referral (‘central’) hos-
pitals situated in the cites of Zomba, Lilongwe, Blantyre and 
Mzuzu. Queen Elizabeth Central Hospital (QECH) in Blantyre 
is the largest central hospital in the country offering specialist 
services for gynaecological oncology, oncology, endoscopy 
and palliative care. Oncology services are at an early stage 
of development with limited specialist capacity and no radio-
therapy available in-country18. Palliative care services have 
been established for adults and children for over fifteen years, 
and are delivered through in-patient referral, out-patient 
clinics, and community based care19,20. Recruitment for this 
study will take place from in-patient wards and out-patient 
clinics (oncology, endoscopy, gynaecological oncology and 
palliative care) at QECH. Patients with hepatocellular carci-
noma will be identified through enhanced case finding via an 
ongoing study on hepatitis B taking place at the same institution.
Participant identification, recruitment and follow-up
Patients with a first-time clinical diagnosis of advanced Kaposi’s 
Sarcoma (KS), or cervical or oesophageal cancer will be 
approached at the site of specialist clinical service (oncology, 
gynaecological oncology, palliative care) at Queen Elizabeth 
Central Hospital (QECH). Patients with hepatocellular carci-
noma (HCC) will be approached via referral from the study 
team. Eligibility screening of all patients will be undertaken 
by the Principal Investigator, following which patients will be 
provided with a study information sheet and invited to pro-
vide written consent. Eligibility criteria, information sheets and 
consent forms have been provided as Extended data21. Once a 
patient has given consent, they will be invited to identify up to 
four household carers who may be approached to take part in 
the study. Any (or all) of these carers will be approached as soon 
as possible after patient recruitment, screened for eligibility, 
and provided with information before being invited to provide 
written consent. Eligibility screening, consent and baseline data 
collection will take place at the hospital, with subsequent data 
collection taking place either at hospital or at the preferred place 
of the participants, either home, hospital or local health centre. 
In the event of patient death, a household member (either the 
carer already consented, or an alternative person identified by 
the previously consented carer) will be invited to consent to 
complete a brief five-item questionnaire on funeral costs. This 
data will be gathered no less than two weeks following the 
death of the patient.
Inclusion: cancer types and diagnostic criteria
Three cancer types (KS, cervical, oesophageal) have been 
selected because they have the highest incidence in the local 
setting22,23, and because they are amenable to clinical diagnosis 
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under routine care at specialist clinics at QECH. Hepatocellular 
carcinoma is another common malignancy24, which is currently 
under surveillance on the medical wards at QECH as part 
of an ongoing study on hepatitis B in Malawi. Recruitment 
will rely on clinical diagnosis under the supervision of spe-
cialist clinicians, as standard of care for diagnosis in the local 
setting (Table 1) for criteria used for diagnosis of ‘advanced’ 
cancer, according to disease type). Histological confirma-
tion is not mandatory, waiting for biopsy result would result 
in significant delays25. Cancer staging will be recorded where 
available.
Study tools
Prior to this study, preliminary work was undertaken to explore 
household concepts of wellbeing and cost areas of impor-
tance to patients following a diagnosis of advanced cancer26. 
Following this, we adapted the WHO TB patient cost survey 
for a cancer population as the Patient-and-Carer Cancer Cost 
(PaCCCt) survey, details of this process and resulting survey 
content have been reported elsewhere27. A locally validated 
Chichewa language translation of the EQ-5D-3L (paper based) 
and the Integrated Palliative Care Outcome Scale (IPOS 
http://pos-pal.org, tablet based) will be used to record changes 
in wellbeing over time. All newly developed content in the sur-
veys have been translated into Chichewa and piloted amongst 
patients and carers receiving palliative care for advanced 
cancer27. Multiple reviews of these questions were conducted 
with experienced fieldworkers during transition from paper-
based to tablet-based format. New questions have also been back 
translated for quality control by the Malawi-Liverpool-Wellcome 
Trust Clinical Research Programme (MLW) Translation Unit to 
ensure consistency of questioning during data collection.
The PaCCCt survey records details of healthcare utilisation 
from time of onset of symptoms (at the baseline visit conducted 
at the time of diagnosis) or since the last visit (for follow up 
visits). Households are asked to provide details of frequency 
of visits, type of provider, and length of visit (including 
transportation to and from provider) as details necessary 
for calculation of all direct and indirect household expendi-
ture on health. Visits to conventional (hospital and health 
centre) and non-conventional (traditional healers, drugstores) 
healthcare providers will be recorded. At subsequent follow-
up study visits, details of emergency (unplanned) and routine 
(planned) visits will be recorded separately. Coping strate-
gies (including loans and dissaving) and sources of fund-
ing for healthcare utilisation are also recorded. Household 
income will be captured by self-report and via use of an 
asset score based on a locally developed proxy means test for 
poverty. The Malawi Urban Proxy Means Test for Poverty was 
originally developed by Payongayong et al.28 The parameters 
for this test have recently been updated by one of us (PM) 
using data from the 2016–2017 Integrated Household Survey.
Primary outcome
Change in total household OOPE on health, as a propor-
tion of annual household income (based on income before the 
onset of illness) from diagnosis to six months.
Table 1. Diagnostic criteria for advanced cancer.
Cancer type Diagnostic criteria for advanced disease
Kaposi’s sarcoma ALL patients with a first-time diagnosis on clinical examination by specialist doctor 
AND 
assessed as AIDS Clinical Trials Group (ACTG) ‘poor risk’ category 
OR 
ALL with a first-time diagnosis of KS where staging not done
Cervical cancer ALL patients with a first-time diagnosis on clinical examination by specialist doctor 
AND 
with disease at International Federation of Gynaecology and Obstetrics (FIGO) stage 2 and above 
OR 
ALL with a first-time diagnosis (where staging not done)
Oesophageal cancer ALL patients with a first-time diagnosis on endoscopy by specialist doctor 
AND 
assessed as being inoperable, 
OR 
ALL with a first-time diagnosis (where no management plan/staging stated)
Hepatocellular carcinoma ALL patients identified with a liver mass followed by confirmatory ultrasound with mass >2cm 
performed by a specialist doctor 
AND 
evidence of local mass effect. 
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Secondary outcomes
Change in index health status and/or frequencies by level 
within dimensions within the EQ-5D-3L and/or visual analogue 
scores from time of diagnosis to six months.
Changes in symptom burden and/or self-reported experience 
of physical/psychological/spiritual symptom burden using 
Integrated Palliative Care Outcome Scale.
Study results will be reported using the STROBE guidelines.
Receipt of palliative care will be presented as both categori-
cal (yes [any] / no [none]) variables, or as interval data (based 
on the number of contacts with palliative care services from 
baseline to six months).
Poverty status will be derived from two approaches, firstly 
self-reported household income before the onset of symp-
toms and secondly from a proxy means test for poverty (derived 
from Malawi Demographic Health Survey 2006–7) based on 
household assets. Household poverty status will be presented 
as tertiles – least poor, poor and non-poor.
Mean (and confidence intervals) and median (and inter-quartile 
ranges) values will be used to describe the characteristics of the 
study cohort for continuous variables. Categorical variables 
will be summarised by frequency tables and bar charts. 
The effect of receipt of palliative care on household expendi-
ture will be estimated using a multiple linear regression model, 
adjusted for expenditure at diagnosis and other potential 
confounding variables (age, sex, rural/urban dwelling).
Poisson regression will be used to assess the relationship 
between the number of palliative care visits and change in 
total household expenditure on health (as a proportion of total 
household income) from the time of diagnosis to six months.
The unadjusted hazard of death will be estimated using the 
Kaplan-Meier survival estimator. Survival will be disaggre-
gated by poverty status, sex, number of palliative care visits 
and cancer type. Cox proportional hazard models will investi-
gate risk factors for death by calculating hazard ratios and 95% 
confidence intervals. The validity of the proportional hazards 
assumption for the Cox models will be tested. Log rank 
tests will be used to test for difference in survival curves 
between different groups.
Sample size
The sample size calculation for this study was powered to 
detect a medium effect (as determined by Cohen’s f2=0.15) of a 
predictor in a multiple linear regression model for change in total 
household OOPE as a proportion of annual household income. 
All power analyses are based on alpha = 0.05; power=0.8, 
using two sided tests.
Comparing single variables (e.g. response variable = change 
in total household OOPE as a proportion of annual household 
income, predictor = receipt of palliative care) a sample 
size of 55 households is required to detect a medium effect. 
Considering 50% exclusions and 20% dropout a sample size 
of 138 households is required (n= 55 / ((1-0.5)*(1-0.2)) = 138).
Following review of local data from relevant clinics at QECH, 
an estimated 225 patients are available for recruitment over 
a six-month period.
Loss to follow-up
Loss to follow-up may be high in this study population, 
who have a diagnosis of advanced cancer with a high risk of 
mortality over the six-month study period. At the time of recruit-
ment participants will be asked to provide details of directions 
to reach their household and asked their preferred place for 
follow-up visits. If they are absent from home on the first home 
visit, a further two visits will be attempted by the research 
team before declaring the household lost to follow-up. Phone 
contact will be tried a maximum of three times before a 
participant household will be considered lost to follow-up.
Participant households will be given 500MK ($0.75) mobile air-
time at each visit to use in the event of any change of address 
or patient status during the study. In addition, the study team 
will call patients and their carers between scheduled visits to 
check on status and current place of residence. In accordance 
with local guidelines for compensation of research partici-
pants, transport costs for all follow-up visits at the hospital 
will be reimbursed and participants will be given sugar, 
tea (at each visit) and local currency equivalent of $10 per 
completed visit (at study completion)29,30. 
Plans for dissemination of outcome and associated data 
once completed
Feedback to the local academic and clinical community 
will be given through participation at local research and 
clinical meetings. A report of the study will be submitted to the 
local ethical committee who provided ethical permission and 
communicated to the broader research community via academic 
presentations (poster and oral) and publications. A follow-up 
meeting will be convened with the national policy making 
forum engaged at the start of the study.
Data will be shared within the research community through 
an open access repository once peer reviewed publication is 
complete.
Clinical care
It is anticipated that due to the underlying diagnosis of advanced 
cancer, the health status of many patients recruited will dete-
riorate during the study, and several will die as a result of their 
cancer illness. The role of the study team is not to provide 
clinical care; however, participants will be advised to use local 
health services (health centre, district or central facilities) 
whenever they are found to be unwell and/or with extreme/ 
unrelieved symptoms at the time of a study visit. Responsibility 
for their care (including any treatment, referrals or admission) 
will remain with locally available health facilities to preserve 
the integrity of the study. 
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Distress protocol
A distress protocol will be developed for study staff to alert 
the principal investigator (or nominated deputy) in the event 
of extreme distress in participants.
Recognition and management of risk to study staff
Following initial training, weekly meetings will be held with 
study staff to check on their work-related wellbeing. The 
principal investigator will be available by phone to assist study 
staff whilst they are in the field should they experience any 
difficulties in the course of their duties. Training delivered by 
palliative care team members who are experienced in provid-
ing bereavement support in local communities will prepare 
study staff to handle issues around death and dying and how to 
administer the funeral cost section of the PaCCCt survey. 
Study limitations
This is a single centre study recruiting patients and their 
carers from urban and peri-urban settings in Blantyre, Malawi. 
Patients with four cancer types will be recruited. Study outcomes 
may have limited generalisability to rural settings and other 
cancer types. Other common life-limiting illnesses (such as 
stroke and chronic lung disease) would need separate study 
due to illness variability in terms of progression, treatment 
options and outcomes. Generalisability to more well-resourced 
health settings is also limited, as cancer treatment protocols 
vary based on availability of resources, e.g. if radiotherapy 
was available in Malawi, OOPE would potentially increase due 
to the requirement for multiple hospital visits, though other 
outcome benefits may also be anticipated.
In common with many studies reporting OOPE31, much of 
the data relies on accurate self-reporting of information about 
healthcare utilisation, household income and costs. Patients and 
carers may for various reasons under or over report these data. 
Use of trained research field staff and regular meetings with 
the team during data collection will attempt to optimise the 
quality of data.
The sample size is likely to be underpowered as a result of 
using Cohen’s f2. Exposure to palliative care will be based 
on routine practice and may be insufficient to infer associa-
tion. It maybe that those choosing not to participate in the study 
will introduce selection bias in the sample.
Current study status
Recruitment began in January 2019 and baseline data were 
collected from 152 households by the end of July 2019. 
Follow-up is ongoing, due to be completed at the end of January 
2020.
Conclusions
Cancer prevalence and mortality are increasing in many LMICs, 
including those in the African region. There are currently 
limited data on healthcare utilisation and related OOPE 
following a diagnosis of cancer in Malawi, where people are 
typically diagnosed during an economically productive stage of 
life with disease already at an advanced stage. During a serious 
illness and following death, the impact of excessive spend-
ing on health continues to be experienced by households, 
disproportionately so by those already adversely affected 
by poverty. 
This study will investigate household wellbeing and poverty 
status in patients receiving a first-time clinical diagnosis for 
advanced cancer, to explore whether there is evidence that 
receipt of palliative care can support a reduction in total house-
hold expenditure on health whilst maintaining (or improving) 
wellbeing in households affected by advanced cancer.
Data availability
Underlying data
No data are associated with this article
Extended data
Open Science Framework: Safeguarding the Family. https://doi.
org/10.17605/OSF.IO/MDN7K21
-    Patient information sheets English Chichewa.docx
-    Consent forms patient carer English Chichewa to 
send.docx
-    Patient and carer eligibility criteria.docx
-    PaCCCt survey English and Chichewa.docx
-    IPOSv1_ChichewaMLW.doc
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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